Rythmodan 100 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

rythmodan 100 mg hard caps.

cheplapharm arzneimittel gmbh - disopyramide 100 mg - capsule, hard - 100 mg - disopyramide 100 mg - disopyramide

Rythmodan 250 mg Long Action tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

rythmodan 250 mg long action tabl. prol.-rel.

cheplapharm arzneimittel gmbh - disopyramide phosphate 322,5 mg - eq. disopyramide 250 mg - prolonged-release tablet - disopyramide phosphate 322.5 mg - disopyramide

Ritmodan 100mg Hard Capsules Malta - English - Medicines Authority

ritmodan 100mg hard capsules

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - disopyramide - hard capsule - disopyramide 100 mg - cardiac therapy

RYTHMODAN 100 mg, capsules Malta - English - Medicines Authority

rythmodan 100 mg, capsules

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - disopyramide - capsule - disopyramide 100 mg - cardiac therapy

Disopyramide 100mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

disopyramide 100mg capsules

medihealth (northern) ltd - disopyramide - oral capsule - 100mg

Disopyramide 150mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

disopyramide 150mg capsules

medihealth (northern) ltd - disopyramide - oral capsule - 150mg

RITMODAN 100 mg hard capsules Malta - English - Medicines Authority

ritmodan 100 mg hard capsules

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - hard capsule - disopyramide 100 mg - cardiac therapy

Disopyramide 250mg modified-release tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

disopyramide 250mg modified-release tablets

imported - disopyramide phosphate - modified-release tablet - 250mg

Rythmodan 100mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

rythmodan 100mg capsules

imported (canada) - disopyramide - oral capsule - 100mg

RYTHMODAN disopyramide 150 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rythmodan disopyramide 150 mg capsule blister pack

pharmaco australia ltd - disopyramide, quantity: 150 mg - capsule, hard - excipient ingredients: magnesium stearate; maize starch; purified talc; gelatin; titanium dioxide; pregelatinised maize starch - management of documented ventricular arrhythmias, e.g. sustained ventricular tachycardia, which are judged to be life threatening. because of its proarrhythmic potential, the use of disopyramide is not recommended for lesser arrhythmias. treatment of asymptomatic ventricular premature contractions should be avoided. in patients with structural heart disease, proarrhythmia and cardiac decompensation are a special risk associated with antiarrhythmic drugs. special caution should be exercised when prescribing disopyramide for these patients. (see precautions.)